Quicksearch Help

(Click the icon to keep this page displayed.)

EMAGE:3835

Gpc3 glypican 3 ( MGI:104903)
TS17 (10.5 dpc)
in situ hybridisation

Data Images
EMAGE:3835 EMAGE:3835 EMAGE:3835 EMAGE:3835 EMAGE:3835
Raw signal output, as movie. All sections along the X-axis, as movie. All sections along the Y-axis, as movie. All sections along the Z-axis, as movie. Photograph prior to 3D imaging.
EMAGE:3835
Sample morphology following 3D imaging, as movie

View 3D opt image: EMAGE genex expression entry
Download 3D images in woolz format
Expression pattern clarity: two stars
Find spatially similar wholemount expression patterns: Find spatially similar wholemount patterns
Notes:
This is a traditionally produced wholemount in situ hybridisation stained using alkaline phosphatase + NBT/BCIP. It has been imaged using Optical Projection Tomography. The visible channel depicting the signal has been false-coloured green and the fluorescence channel depicting autofluorescence has been false-coloured red.
Expression Pattern Description
Spatial Annotation:
EMAGE:3835Annotation colour key:  
strong strong      
gene expression moderate moderate    
gene expression weak weak        
gene expression possible possible    
gene expression not detected not detected
wholemount mapping

Download individual expression domains:
3835_wholemount_strong_3D_1.wlz
3835_wholemount_moderate_3D_1.wlz
3835_wholemount_weak_3D_1.wlz
3835_wholemount_possible_3D_1.wlz
3835_wholemount_notDetected_3D_1.wlz
(what is wlz format?)
Download all expression domains: EMAGE:3835_all_domains.zip
Find spatially similar wholemount expression patterns:  EMAGE spatially similar wholemount patterns
Morphological match to the template: two stars
Text Annotation:
StructureLevelPatternNotes
axial skeleton
moderate moderate
forelimb bud
strong strong
1st branchial arch
strong strong
Strong expression in the maxilliary prominence. Weaker expression in the mandible
2nd branchial arch
moderate moderate
3rd branchial arch
possible possible
hindlimb bud
moderate moderate
Annotation Validation: EMAGE Editor
Detection Reagent
Type:in situ hybridisation probe
Identifier:Gpc3_T7
Entity Detected:Gpc3, glypican 3 ( MGI:104903)
Sequence:sense strand is shown

>Gpc3_T7
TTTGTCAAAGAAATCCATGCAGAGAAAGAGAAAAGAGGGAAACATGACAACCATGTTCCAACAGTCAAAT
GTAAGAAAATAATTTGGCACAACTTGAAGGTTTTTTTTTTCTTTGCAAAAAGACAATCTATCCTACCACT
AAAATTTACCATCCTCATAAAGATACCATTTGATTTTCGAAAACATAACACGCGGTTAGTCTCCTACTTA
ATGGTGGTGGGAGGAGGCATAAAAGATAAAAAAAAAAAAAAAAAGAAAAAAAAAAGAAGGTGGCTCCCTT
TCTGTAGGGACCACAGGTGCTGCAGGGCAGCACAGGCACTGGACGCTGGCAAGTCAGTGCACCAGGAAAA
AAAAGCACGCCACATAGATGGCCACACTGATGAGGATCTTCAGTGGGGACGGCATGTTCCCCACGCTGTG
AGAGGTGGTGATCTCGTTGTCCTTCTGATTTCCATGCTGCTTGTTCCCCGGAGCATCGTCCACATCCAGA
TCATAGGCC
nt 48517079 - nt 48517577 of NC_000086.5
Notes:These primers were used to generate the in vitro transcription template by PCR of mouse whole genomic DNA. They contain T7 or T3 promotor sequences and amplify a region corresponding to portions of the ORF and the 3'UTR. Forward primer: 5 AATTAACCCTCACTAAAGGGGCCTATGATCTGGATGTGG (T3 Sense) Reverse primer: 5 TAATACGACTCACTATAGGTTTGTCAAAGAAATCCATGCAG (T7 Antisense)
Chemistry:RNA
Strand:antisense
Label:digoxigenin
Specimen
Organism:mouse
Strain:CD1
Age:10.5 dpc
Theiler Stage:TS17
Mutations:none (wild-type)
Preparation:opt
Procedures
Fixation:4% paraformaldehyde
Embedding:agarose
Staining procedure:alkaline phosphatase + NBT/BCIP
General Information
Authors:Jacqueline Ramsay, David R FitzPatrick
Principal investigator:David R FitzPatrick, Medical Research Council, Human Genetics Unit MRC Western General Hospital Crewe Road, Edinburgh, Scotland EH4 2XU
Submitted by:Jacqueline Ramsay, Medical Research Council, Human Genetics Unit MRC Western General Hospital Crewe Road, Edinburgh, Scotland EH4 2XU
Experiment type:screen
Links: Ensembl same gene
  Allen Brain Atlas same gene
  BioGPS same gene
  International Mouse Knockout Project Status same gene
  GEISHA Chicken ISH Database same gene
  EMBL-EBI Gene Expression Atlas same gene
  BrainStars same gene
  ViBrism same gene
Data SourceFACEBASE